Research Projects & Grants

Internal

• Consequences of Withholding Erythropoiesis-Stimulating Agents in Hospitalized Patients, Role: PI, LLU Dept. of Pharmacy Practice, (08/2024) Status: Approved
• Assessing hypertension management and establishing targets in adult inpatients undergoing hemodialysis, Role: PI, LLU Dept. of Pharmacy Practice, (05/2024) Status: Approved
• Efficacy and safety of antihypertensive additions in medicine inpatients admitted with acute kidney injury with pre-existing hypertension, Role: PI, LLU Dept. of Pharmacy Practice, (05/2024) Status: Approved
• Evaluating the efficacy and safety of DOACs in cirrhotic patients: Child Turcotte Pugh Class B and Beyond, Role: PI, LLU Dept. of Pharmacy Practice, (09/2023) Status: Approved
• Comparison of Sodium Zirconium Cyclosilicate and Sodium Polystyrene Sulfonate in the Treatment of Acute Hyperkalemia, Role: Investigator, LLU Dept. of Pharmacy Practice, (09/2023) Status: Approved
• Comparison of direct oral anticoagulants (DOACs) for the treatment of cerebral venous thrombosis, Role: PI, LLU Dept. of Pharmacy Practice, (10/2022) Status: Approved
• Evaluating ceftriaxone dosing for the treatment of spontaneous bacterial peritonitis (SBP), Role: PI, LLU Dept. of Pharmacy Practice, (10/2022) Status: Approved
• Evaluation of Lokelma versus Kayexalate Monotherapy for Acute Hyperkalemia Treatment, Role: PI, LLU Dept. of Pharmacy Practice, (04/2022) Status: Approved
• Use of the Nominal Group Technique to Explore Skills Lab Faculty and Preceptor Perceptions of EPA Readiness, Role: PI, LLU Dept. of Pharmacy Practice, (08/2021 - 06/2023) Status: Completed
• An International Perspective on Important Components for Successful International Pharmacy Collaborations, Role: PI, LLU Dept. of Pharmacy Practice, (07/2021 - 01/2023) Status: Completed
• Ivabradine Therapy Appropriateness and Its Implications for Heart Failure Patients, Role: PI, LLU Dept. of Pharmacy Practice, (03/2021) Status: Approved
• Comparison of the clinical outcomes of piperacillin-tazobactam versus cefepime in the treatment of hospital- acquired pneumonia with mechanical ventilation and/or septic shock, Role: PI, LLU Dept. of Pharmacy Practice, (09/2020 - 10/2021) Status: Completed
• Clinical comparison of carvedilol immediate release (IR) versus controlled release (CR) in patients with heart failure with reduced ejection fraction (HFrEF), Role: PI, LLU Dept. of Pharmacy Practice, (09/2020 - 08/2022) Status: Completed
• The effect of the COVID-19 pandemic on the prescribing practices of opioid and opioid use, Role: Investigator, LLU Dept. of Pharmacy Practice, (09/2020) Status: Approved
• Comparing ceftriaxone dosing in SBP patients, Role: PI, LLU Dept. of Pharmacy Practice, (07/2020 - 02/2021) Status: Completed
• Hydration to prevent acute tubular necrosis with intravenous acyclovir (HYNIVA), Role: PI, LLU Dept. of Pharmacy Practice, (02/2020) Status: Approved
• Comparison of sevelamer hydrochloride and sevelamer carbonate in patient outcomes and cost, Role: PI, LLU Dept. of Pharmacy Practice, (01/2020 - 11/2021) Status: Completed
• Impact of naloxone mandate on naloxone prescribing for reversal of opioid overdose, Role: Investigator, LLU Dept. of Pharmacy Practice, (12/2019) Status: Approved
• The effect of the CURES mandate on prescribing practices of class II - IV controlled substances and naloxone, Role: PI, LLU Dept. of Pharmacy Practice, (12/2019 - 07/2023) Status: Completed
• Loading vs. No loading of Apixaban in ESRD patients with VTE, Role: PI, LLU Dept. of Pharmacy Practice, (12/2019 - 01/2023) Status: Completed
• Assessment of enoxaparin thromboprophylaxis dosing and anti-factor Xa levels in low-weight patients, Role: PI, LLU School of Pharmacy, (09/2015) Status: Completed
• A retrospective study determining the appropriate dosing of epoetin alfa for initiation and titration in patients with anemia of chronic kidney disease, Role: PI, LLU Dept. of Pharmacy Practice, (10/2024) Status: Approved